The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $5,678.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 100 mg/mL Nucala auto-injectors and has an ultimate completion date of December 10, 2024. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group has demonstrated its capability to provide a diverse array of prescription drugs, over-the-counter medications, biologics, and medical consumables to the Department of Defense. The contract does not have a set-aside designation.
Generated 3/16/25, 12:46 AM